Clinical Trial

Evaluate the Efficacy and Safety of VV913 Capsules in the Treatment of PE

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This trial adopted a multicenter, randomized, double-blind, placebo-controlled design and consisted of two parts: Part Ⅰ and Part Ⅱ.
Trial Details
NCT Number NCT07722780
Lead Sponsor Vigonvita Life Sciences
Conditions Premature Ejaculation
Enrollment 500 participants
Start Date 2026-08-31
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-23